205 related articles for article (PubMed ID: 29478352)
1. Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis.
Tang M; Price TJ; Shapiro J; Gibbs P; Haller DG; Arnold D; Peeters M; Segelov E; Roy A; Tebbutt N; Pavlakis N; Karapetis C; Burge M
Expert Rev Anticancer Ther; 2018 Apr; 18(4):339-349. PubMed ID: 29478352
[TBL] [Abstract][Full Text] [Related]
2. Translating IDEA to Practice and Beyond: Managing Stage II and III Colon Cancer.
Gill S; Meyerhardt JA; Arun M; Veenstra CM
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():226-235. PubMed ID: 31099666
[TBL] [Abstract][Full Text] [Related]
3. Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline.
Lieu C; Kennedy EB; Bergsland E; Berlin J; George TJ; Gill S; Gold PJ; Hantel A; Jones L; Mahmoud N; Meyerhardt J; Morris AM; Ruíz-García E; You YN; Baxter N
J Clin Oncol; 2019 Jun; 37(16):1436-1447. PubMed ID: 30986117
[TBL] [Abstract][Full Text] [Related]
4. A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.
Margalit O; Mamtani R; Yang YX; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Eur J Cancer; 2018 Jun; 96():105-110. PubMed ID: 29698932
[TBL] [Abstract][Full Text] [Related]
5. The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
Sobrero A; Grothey A; Iveson T; Labianca R; Yoshino T; Taieb J; Maughan T; Buyse M; André T; Meyerhardt J; Shields AF; Souglakos I; Douillard JY; Cervantes A
Ann Oncol; 2018 May; 29(5):1099-1107. PubMed ID: 29438451
[TBL] [Abstract][Full Text] [Related]
6. Changes in Prescribing Patterns in Stage III Colon Cancer.
Ou FS; Walden DJ; Larson JJ; Kang S; Griswold CR; Ueberroth BE; Patel B; Draper A; Raman P; Alese OB; Sonbol MB; Bekaii-Saab TS; Wu CS; Ahn DH
J Natl Compr Canc Netw; 2023 Aug; 21(8):841-850.e4. PubMed ID: 37549913
[TBL] [Abstract][Full Text] [Related]
7. Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?
Formica V; Zaniboni A; Loupakis F; Roselli M
Int J Cancer; 2018 Nov; 143(10):2342-2350. PubMed ID: 29873066
[TBL] [Abstract][Full Text] [Related]
8. Optimizing adjuvant therapy and survivorship care of stage III colon cancer.
Loree JM; Cheung WY
Future Oncol; 2016 Sep; 12(17):2021-35. PubMed ID: 27301775
[TBL] [Abstract][Full Text] [Related]
9. New adjuvant therapy for colon cancer: justified hope or commercial hype.
Galanis E; Alberts SR; O'Connell MJ
Surg Oncol Clin N Am; 2000 Oct; 9(4):813-23; discussion 825-6. PubMed ID: 11008249
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review.
Meyers BM; Cosby R; Quereshy F; Jonker D
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):459-465. PubMed ID: 28341242
[TBL] [Abstract][Full Text] [Related]
11. Trends and Prescriber Variation in the Duration of Oxaliplatin-Containing Adjuvant Chemotherapy for Stage III Colon Cancer From 2007 to 2019: A Population-Based Retrospective Cohort Study.
Sue-Chue-Lam C; Brezden-Masley C; Sutradhar R; Yu AYX; Baxter NN
Clin Colorectal Cancer; 2023 Dec; 22(4):431-441.e9. PubMed ID: 37648568
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.
Jonker DJ; Spithoff K; Maroun J;
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):314-22. PubMed ID: 21397476
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy in colon cancer--what, when and how?
Chau I; Cunningham D
Ann Oncol; 2006 Sep; 17(9):1347-59. PubMed ID: 16524974
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy in colon cancer: state of the art and future perspectives.
Iveson T
Curr Opin Oncol; 2020 Jul; 32(4):370-376. PubMed ID: 32541327
[TBL] [Abstract][Full Text] [Related]
15. The Adjuvant Treatment of Stage III Colon Cancer: Might Less Be More?
Lee JJ; Chu E
Oncology (Williston Park); 2018 Sep; 32(9):437-42, 444. PubMed ID: 30248163
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy for completely resected stage II colon cancer.
Figueredo A; Coombes ME; Mukherjee S
Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD005390. PubMed ID: 18646127
[TBL] [Abstract][Full Text] [Related]
17. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S
Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy for colon cancer.
Saltz LB
Surg Oncol Clin N Am; 2010 Oct; 19(4):819-27. PubMed ID: 20883956
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy of colon cancer: current status and future directions.
Chung KY; Saltz LB
Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
[TBL] [Abstract][Full Text] [Related]
20. Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.
Yu IS; Pereira AAL; Lee M; Korphaisarn K; Marshall J; Segelov E; O'Callaghan C; Lim HJ; Kopetz S; Loree JM
Oncologist; 2020 Mar; 25(3):229-234. PubMed ID: 32162828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
